The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-((R)-2-((R,E)-4,4-difluoro-3-hydroxy-4-phenylbut-1-enyl)-5-oxopyrrolidin-1-yl)heptanoic acid ID: ALA1956372
PubChem CID: 10272021
Max Phase: Preclinical
Molecular Formula: C21H27F2NO4
Molecular Weight: 395.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CCCCCCN1C(=O)CC[C@@H]1/C=C/[C@@H](O)C(F)(F)c1ccccc1
Standard InChI: InChI=1S/C21H27F2NO4/c22-21(23,16-8-4-3-5-9-16)18(25)13-11-17-12-14-19(26)24(17)15-7-2-1-6-10-20(27)28/h3-5,8-9,11,13,17-18,25H,1-2,6-7,10,12,14-15H2,(H,27,28)/b13-11+/t17-,18+/m0/s1
Standard InChI Key: HWLGHEIVNKULQQ-SLKVGHROSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
-1.4167 0.2750 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.0000 -0.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5877 0.2775 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.8167 0.3750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.1022 0.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5933 0.6665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1077 0.0215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6532 -0.6671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8577 -0.4474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8128 1.4618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.1426 -0.8588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4288 -0.4451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7136 -0.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7123 -1.6815 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2847 -0.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2848 -1.6802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4295 -2.0915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1443 -1.6778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1403 -0.8486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4254 -0.4410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1022 1.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3877 2.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6733 1.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9588 2.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2443 1.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4702 2.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1846 1.6125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4702 2.8500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13 14 1 6
6 7 1 0
2 15 1 0
7 8 1 0
15 16 2 0
8 9 1 0
16 17 1 0
9 4 1 0
17 18 2 0
4 6 1 0
18 19 1 0
6 10 2 0
19 20 2 0
20 15 1 0
3 2 1 0
5 21 1 0
9 11 1 1
21 22 1 0
22 23 1 0
11 12 2 0
23 24 1 0
2 1 1 0
24 25 1 0
12 13 1 0
25 26 1 0
13 2 1 0
26 27 1 0
4 5 1 0
26 28 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 395.45Molecular Weight (Monoisotopic): 395.1908AlogP: 3.72#Rotatable Bonds: 11Polar Surface Area: 77.84Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.29CX Basic pKa: ┄CX LogP: 3.36CX LogD: 0.39Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.44Np Likeness Score: 0.09
References 1. Arns S, Gibe R, Moreau A, Monzur Morshed M, Young RN.. (2012) Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis., 20 (6): [PMID:22341574 ] [10.1016/j.bmc.2012.01.024 ]